PharmiWeb6h
ModMed Named Leader in Physician Practice EHR Software for 11 Specialties in 2025 Black Book Awards
TAMPA, FLORIDA / ACCESS Newswire / January 16, 2025 / ModMed continues to dominate the field of physician practice electronic health record (EHR) software, earning top honors in the 2025 Black Book ...
PharmiWeb7h
Veos Pharmaceuticals Launches ThymoTropin™ to Support Muscle Health and Preservation on Weight Loss and Aging Journeys
Targeting Formula to Enhance Muscle Growth, Repair, and Endurance MADRID, SPAIN / ACCESS Newswire / January 16, 2025 / Veos Pharmaceuticals, a leading innovator with a portfolio of nearly 40 products ...
PharmiWeb1d
BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced today the launch of a new ...
PharmiWeb1d
Oxford Drug Design achieves further in vivo validation of novel approach against multiple tumours
Oxford Drug Design, the Oxford-based AI drug discovery company, has today announced additional in vivo validation for its first-in-class approach against cancer as the Company continues to apply its ...
PharmiWeb1d
Handa Therapeutics Acquires FDA Approved Chronic Myeloid Leukemia Drug, PHYRAGO (dasatinib) Tablets
PHYRAGO™ Represents the First and Only Improved Version of SPRYCEL® That Can Be Safely Co-administered With Gastric Acid-Reducing Agents TAIPEI, TAIWAN / ACCESSWIRE / January 15, 2025 / Handa ...
PharmiWeb1d
Cellev8 Nutrition Teams Up With NFL Hall of Famer Andre Reed to Revolutionize Wellness, on and Off the Field
Cellev8's Brand Expands Beyond Consumers  WELLINGTON, FLORIDA / ACCESSWIRE / January 15, 2025 / Cellev8 Nutrition Inc., a leader in natural health supplements, is proud to announce an exclusive ...
PharmiWeb1d
Drägerwerk AG & Co. KGaA: Preliminary figures 2024…
Forecast for 2025 For the current fiscal year, Dräger expects an increase in net sales of 1.0 to 5.0 percent (net of currency effects) and an EBIT margin of 3.5 to 6.5 percent. The expected EBIT ...
PharmiWeb1d
Black Book Research Announces the Release of "The 2025 Black Book of Healthcare IT Consultants and Advisory Firms"
Comprehensive Gratis Report Featuring Profiles and Client Engagement Ratings for 260 HIT Consulting and Advisory Firms TAMPA, FLORIDA / ACCESSWIRE / January 15, 2025 / Black Book Research announces ...
PharmiWeb1d
Laxxon Medical Announces Positive Pilot PK Study Results (in Pigs) for Groundbreaking Oral GLP-1 Dosage Form
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug delivery systems, today announced the ...
PharmiWeb1d
Aptevo's Peter Pavlik, PhD, Chairing Session on "Bi and Multispecific Biologics" at Cambridge Healthcare Institute's Pep Talk 2025
Also giving an in-session talk titled "Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the ADAPTIR® Platform," showcasing Aptevo's drug engineering and rational drug design ...
PharmiWeb1d
Telangiectasia Treatment Now Available at Skin & Laser Dermatology Center
Dr. Amir Bajoghli and Skin & Laser Dermatology Center are excited to introduce advanced laser treatments for telangiectasia, offering patients effective solutions to reduce the appearance of small, ...
PharmiWeb1d
Vetter Introduces the Next Evolution of the V-OVS® Syringe Closure System
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe closure ...